Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were described at first in the heritable connective tissue disorder, Marfan syndrome (MFS). More recently, FBN1 has also been shown to harbor mutations related to a spectrum of conditions phenotypically related to MFS and many mutations will have to be accumulated before genotype/phenotype relationships emerge. To facilitate mutational analysis of the FBN1 gene, a software package along with a computerized database (currently listing 63 entries) have been created.
INTRODUCTION
Fibrillin is a large glycoprotein (320 kDa) ubiquitously distributed in connective tissues (1) . Together with amorphous elastin, fibrillin-containing microfibrils form the elastic fibers. Fibrillin is also found in microfibrils that are apparently unendowed with amorphous elastin, such as those forming the ciliary zonule (1) . FBN1 gene mutations are associated not only with the Marfan syndrome (MFS) (2, but also with a spectrum of conditions phenotypically related to MFS, including dominantly inherited ectopia lentis (12, 15) , severe neonatal Marfan syndrome (12, 17, 19, 23) , and isolated typical features of MFS (12, 14, 18, 20, 22, 25, 26) . Marfan syndrome, the founding member of heritable disorders of connective tissue, is a dominantly inherited condition characterized by tall stature and skeletal deformities, dislocation of the ocular lens and propensity to aortic dissection (2) . The syndrome is characterized by considerable variation in the clinical phenotype between families and also within the same family. Ectopia lentis (EL) is a dominantly inherited connective tissue disorder that somewhat overlaps MFS. In the literature, there are reports both of isolated EL (27, 28) and of families in which EL is associated with mild skeletal symptoms (29) . The fundamental difference with MFS is the absence of cardiovascular involvement, an absolute criterion for MFS. Severe neonatal MFS has features of the Marfan syndrome and of congenital contractural arachnodactyly (CCA) present at birth, along with unique features such as loose, redundant skin, cardiac malformations and pulmonary emphysema (30, 31) .
The gene for FBN1 is located at chromosome 15q15-q21.1 (32) . It is relatively large (∼110 kb) and its coding sequence is highly fragmented (65 exons) (33) (34) (35) . The deduced primary structure shows that the fibrillin gene encodes a 2871 amino acid protein that is multidomain and highly repetitive. The protein contains 47 tandem domains with homology to a motif found in human epidermal growth factor (EGF) precursor (33, 34) . This motif is characterized by a conserved arrangement of 6 cysteineresidues that form 3 predictably spaced intramolecular disulfide linkages resulting in an antiparallel β-sheet conformation (36, 37) . In 43 of the 47 EGF-like motifs, a calcium-binding consensus sequence was identified. The study of this motif in other proteins suggests a role in protein-protein, protein-ligand and cell-cell interactions. Interspersed among the EGF like motifs are 7 '8-cysteine' motifs (that are homologous with transforming-growth factor-β1 binding-protein) and two 'hybrid' motifs that combine features of the two former. Finally the last 3 domains found in the protein include a unique N-terminal stretch of basic residues, a proline rich domain and the C-terminal region (34) .
Sixty three mutations in the FBN1 gene have been reported. These mutations are private, essentially missense, non recurrent and widely distributed throughout the gene. To date, no clear genotype/phenotype relationship has been observed. This is not surprising when considering past experience with other disease genes such as the type I procollagen genes for which many mutations were accumulated before genotype/phenotype relationships emerged (38) (39) (40) . In this perspective, and to facilitate * To whom correspondence should be addressed the mutational analysis of FBN1, we have compiled a database (Table 1) and created a software package for its analysis.
DATABASE AND SOFTWARE
In an effort to standardize the information regarding FBN1 mutations, we have created a computerized database that currently contains information about the published mutations of the fibrillin gene FBN1 and some only reported in meetings proceedings. The current version of the database contains 63 entries. For each mutation, information is provided at several levels: at the gene level (exon and codon number, wild type and mutant codon, mutational event, mutation name), at the protein level (wild type and mutant amino acid, affected domain) and at the clinical level (absence or presence of skeletal, ocular, cardiovascular, central nervous system and other various manifestations).
The software package contains routines for the analysis of the FBN1 database that were developed with the 4 th dimensionr (4D) package from ACI. The use of the 4D SGDB gives access to optimized multicriteria research and sorting tools to select records from any field. Moreover, six routines were specifically developed: (i) 'Position' studies the distribution of mutations at the nucleotide level to identify preferential mutation sites, (ii) 'Statistical evaluation of mutational events' is comparable to (i) but also indicates the type of mutational event. The result can either be displayed as a table or in a graphic representation, (iii) 'Frequency of mutations' allows one to study the relative distribution of mutations at all sites and to sort them according to their frequency. A graphic representation is also available and displays a cumulative chart of mutation distributions, (iv) 'Stat exons' studies the distribution of mutations in the different exons. It enables detection of a statistically significant difference between observed and expected mutations (v) 'Protein' studies the distribution of mutational events in various protein domains ('NH2 unique region', 'EGF-like motifs', 'cb EGF-like motifs', '8-cysteine motifs', 'Hybrid motifs', 'Proline' rich region and 'COOH unique region'), and aligns the amino acids of the consensus sequence for each motif type. (vi) 'Insertions and deletions analysis' searches for repeated sequences surrounding the mutation and possibly involved in the mutational mechanism.
Subsequently, the software will be expanded as the database grows and according to the requirements of its users. New functions could be implemented (see accompanying paper).
AVAILABILITY
The current database and subsequent updated versions are (will be) available on request to G.C. or C.Be. on floppy disc using Apple format and Microsoft ExcelR. Notification of omissions and errors in the current version as well as specific phenotypic data would be gratefully received by the corresponding authors. The software package is available on a collaborative basis.
